Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04480502
Title ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma (ENVASARC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications

myxofibrosarcoma

sarcoma

Therapies

Envafolimab + Ipilimumab

Envafolimab

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.